SCHEMBL3972472

SCHEMBL3972472

O=C(NC1CC1)c1cccc2sc(-c3nc(NCCC4CCNC4)ncc3Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.40
CCNT1 O60563 2/20 0.38
CCNK O75909 2/20 0.38
CDK9 P50750 2/20 0.38
CDK12 Q9NYV4 2/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
TYRO3 Q06418 2/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
NTRK1 P04629 10/20 0.37
AXL P30530 2/20 0.36
MERTK Q12866 1/20 0.36
NTRK3 Q16288 2/20 0.35
NTRK2 Q16620 2/20 0.35
CHEK1 O14757 1/20 0.35
CRHR1 P34998 1/20 0.34
ACP1 P24666 1/20 0.34
PTK2 Q05397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3961504 0.95 TYRO3 (0.40) KDM1ACCNT1CCNKCDK9CDK12
Hydrochloric Acid SCHEMBL3966674 0.95 TYRO3 (0.40) KDM1ACCNT1CCNKCDK9CDK12
SCHEMBL3964106 0.91 TYRO3 (0.41) KDM1ACCNT1CCNKCDK9CDK12
Hydrochloric Acid SCHEMBL4089904 0.90 ACP1 (0.44) CCNT1CCNKCDK9CDK12CDK7
Hydrochloric Acid SCHEMBL3965521 0.90 TYRO3 (0.41) KDM1ACCNT1CCNKCDK9CDK12
SCHEMBL13799541 0.87 SIRT5 (0.38) CCNT1CCNKCDK9CDK12CDK7
Hydrochloric Acid SCHEMBL3964027 0.86 TYRO3 (0.42) TYRO3CDK2NTRK1AXLMERTK
SCHEMBL3961594 0.86 TYRO3 (0.40) TYRO3AXLMERTKCHEK1CRHR1
SCHEMBL3961579 0.86 TYRO3 (0.39) TYRO3NTRK1AXLMERTKCHEK1
SCHEMBL3963485 0.86 AURKA (0.40) KDM1ACCNT1CCNKCDK9CDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed
US-7547691-B2 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases ELI LILLY AND COMPANY (US) 2009-06-16 US disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG KDM1A 598/4885CCNT1 1256/4885CCNK 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.